This site uses cookies to provide you with a great user experience. By using BondbloX, you accept our use of cookies.
Wesley Batista, controlling shareholder of JBS, said the world’s largest meat producer sees Europe as a fragmented market with significant acquisition opportunities. Speaking at a panel discussion alongside Marcos Molina of Marfrig and BRF, Batista noted that JBS’s New York listing earlier this year has lowered its cost of capital and broadened its investor base, positioning the company to compete more effectively with global peers such as Tyson. Batista ruled out major acquisitions in the USA and Brazil, citing antitrust restrictions given JBS’s dominant 20–25% share of the beef, pork and chicken markets in these regions. He also highlighted a structural demand boost for protein from the growing use of weight-loss drugs such as Mounjaro and Ozempic, estimating around 15mn Americans as frequent users of such treatments.
JBS’ 3.625% 2032s were trading stable at 93.9, yielding 4.8%.
For more details, click here.